Figure 5.
Figure 5. Survival analysis and white blood cell counts of TCL-1 leukemic mice after fludarabine treatment. (A) Kaplan-Meier survival curve of TCL-1 leukemic mice treated with fludarabine (34 mg/kg intraperitoneally). (B) White blood cell count as determined on blood smear of TCL-1 leukemic mice treated with fludarabine (34 mg/kg intraperitoneally) versus saline control. (C) White blood cell count as determined on blood smear of 1 TCL-1 leukemic mouse treated with fludarabine (34 mg/kg intraperitoneally). Arrows indicate day 1 of 5 days of fludarabine treatment.

Survival analysis and white blood cell counts of TCL-1 leukemic mice after fludarabine treatment. (A) Kaplan-Meier survival curve of TCL-1 leukemic mice treated with fludarabine (34 mg/kg intraperitoneally). (B) White blood cell count as determined on blood smear of TCL-1 leukemic mice treated with fludarabine (34 mg/kg intraperitoneally) versus saline control. (C) White blood cell count as determined on blood smear of 1 TCL-1 leukemic mouse treated with fludarabine (34 mg/kg intraperitoneally). Arrows indicate day 1 of 5 days of fludarabine treatment.

Close Modal

or Create an Account

Close Modal
Close Modal